NCT04869137 2026-04-08
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Alpha Tau Medical LTD.
National Institutes of Health Clinical Center (CC)
Pfizer
University of Southern California